Skip to main content
. 2019 Oct 17;7:e7815. doi: 10.7717/peerj.7815

Figure 2. Rosiglitazone administration accelerated wound closure in db/db diabetic mice.

Figure 2

After 4 weeks treated with RSG, db/db mice were produced a six mm circle wound on the dorsa by a punch biopsy and then pictures of the wound were taken every 2 days until day 14. RSG treatment accelerated wound closure in db/db mice. Representative pictures of wound closure on day 0, day 4, day 8, day12 and day 14 (A–T) and quantitative analysis (U). Values are mean ±SEM, (n = 5 per group). ∗P < 0.05 vs. Control; #P < 0.05 vs. db/db. RSG, rosiglitazone.